"Arab Health ": "Imperial College" It adopts new techniques for diabetics
Dubai, January 28 / WAM / The “Imperial College London Diabetes” Center, part of the “M42” group, signed two new agreements with two medical companies aimed at adopting a new advanced technology dedicated to the care of diabetes, which confirms the center’s commitment to support patients and provide medical services Personal and flour.
The signing ceremony of the two agreements was held within the “M42” platform at the Arab Health Exhibition and Conference “Arabs Health 2025”, which is currently held at the Dubai World Trade Center.
The first agreement was signed with “Medterone”, the provider of technological health care solutions, where the “Imperial College London Diabetes” center currently provides care for more than 1,000 patients in Abu Dhabi using insulin pumps from “Medterone”, and includes the company’s platform with the name of 1000 patients currently Carenink ™.
Under this agreement, patients will be transferred to the “Careconnect” and “Galaxy”, which provide additional advanced advantages to care for the patient by improving periodic follow -up and reducing the patient’s need to visit clinical care cadres in person.
By taking advantage of clinical information in addition to patient data, the platform classifies the priority of cases according to their urgency, as a guarantee of early intervention when needed to provide additional care. Doctors can manage patients remotely via a communication channel specifically designed for that, while patients benefit from easy access to continuous care and remote monitoring.
The platform also enables care partners by activating direct data sharing and quickly sending alerts to mobile phones, as this is from interacting with family members and care providers, reduces the time of response to devices alerts and makes the procedures more quickly. These advantages involve special importance for managing cases that require intervention as quickly as possible, such as diabetes.
Within the agreement, the Imperial College London Diabetes Center will rely on the “Galaxy” platform, which provides custom reports and information so that clinical care specialists can focus on the exact needs of patients and the broader operational goals as the platform allows clinical care cadres, researchers and the institution as a whole to review the data collected for patients, To obtain a comprehensive overview of the patient’s health and develop strategic plans to improve his therapeutic output.
The Embraial Collidge London Diabetes Center has signed the second cooperation agreement with the innovative health care platform, “Karaz”, with the aim of simplifying data integration as care providers currently need to deal with many software platforms to access the data of many continuous insulin and glucose monitoring devices.
The “Karaz” platform will unify patient data within one information panel, which facilitates the tasks of caregivers, improves their work efficiency and creates a comprehensive image of the patient’s health.
“Today we are achieving a remarkable achievement in the framework of our efforts to make a qualitative shift in diabetes care, as the center’s partnership with” Medterone “confirms our continuous efforts to combat diabetes by supporting patients in various possible ways and supporting providers Care to be able to look at the comprehensive image, and learn about the specific risk factors for patients. “
She added that through our partnerships with “Karaz”, we are a new standard for pre -emptive and personal care, and we are not satisfied with adopting the latest technologies, but rather the process of combining it to give people with diabetes an growing ability to manage their health easily and achieve better health results as this step represents a very important achievement to draw new features to care for diabetics , Whether at the local or global level.
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Twitter
